Skip to content

Non-healing soft tissue and malignant wounds in the palliative care setting: applying Sterile Larvae Wound Therapy for wound debridement and healing.

Non-healing soft tissue and malignant wounds in the palliative care setting: feasibility of applying Sterile Larvae Wound Therapy for wound debridement and healing.

Status
Terminated
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12619000920190
Enrollment
1
Registered
2019-07-02
Start date
2019-07-15
Completion date
2019-07-15
Last updated
2021-11-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

Non-healing soft tissue and malignant wounds can be very challenging to treat in the palliative care setting. Instead of complete healing, the goals of care in this setting are to reduce symptoms such as malodour, exudate and pain, to maintain patients’ dignity and to improve quality of life. This study aims to investigate the use of sterile larvae therapy in treating non-healing soft tissue and malignant wounds in the palliative care setting.

Interventions

(1) Sterile larvae therapy Ward nurses will apply the wound therapy. Sterile larvae therapy (medical grade): The normal rate of application is 5-8 larvae per cm2 of wound surface area. The larvae are left on the wound site for 48-72 hours therefore wound dressings will be changed and sterile larvae therapy applied every 2-3 days. Wound assessment will be completed at each dressing change and includes assessment by treating nurses and patient reported assessment (rating pain, odour etc). (2)

(1) Sterile larvae therapy Ward nurses will apply the wound therapy. Sterile larvae therapy (medical grade): The normal rate of application is 5-8 larvae per cm2 of wound surface area. The larvae are left on the wound site for 48-72 hours therefore wound dressings will be changed and sterile larvae therapy applied every 2-3 days. Wound assessment will be completed at each dressing change and includes assessment by treating nurses and patient reported assessment (rating pain, odour etc). (2) Standard wound management practices which vary according to the wound. Allocation is determined by participant consent.

Sponsors

St Vincent's Private Hospital Brisbane
Lead SponsorHospital

Study design

Allocation
Non-randomised trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Open (masking not used)

Eligibility

Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1) with advanced disease who are inpatients of the SVPHB palliative care unit 2) have a non-healing soft tissue or malignant wound with one or more of the following elements o necrotic tissue o malodorous o profuse exudate

Exclusion criteria

1) have an allergy to fly larvae, chicken eggs or soybeans.

Outcome results

None listed

Source: ANZCTR · Data processed: Feb 4, 2026